BenjaminEvansPetersonMDMPH

Cardiology • Edgewood, KY

Interventional Cardiology

Interventional cardiologist Structural heart program Medical Director Heart and Vascular Research Institute

Join to view full profile

Dr. Peterson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Peterson's full profile

Already have an account?

Office
711 Medical Village Dr
Edgewood, KY 41017
Phone+1 859-287-3045

Fax+1 859-578-3800

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2016 - 2019
Duke University HospitalResidency, Internal Medicine, 2013 - 2016
University of Rochester School of Medicine and DentistryClass of 2013

Certifications & Licensure

IN State Medical License 2022 - 2025
KY State Medical License 2022 - 2025
MA State Medical License 2016 - 2023
RI State Medical License 2021 - 2022
NC State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry.
Benjamin E Peterson, Deepak L Bhatt, Christie M Ballantyne, James A de Lemos, Robert S Rosenson
International Journal of Cardiology. 2024-12-17
3 citations
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease.
Benjamin E Peterson, Deepak L Bhatt, Christie M Ballantyne, James A de Lemos, Robert S Rosenson
JAMA Network Open. 2023-03-01
24 citations
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton
Journal of the American Heart Association. 2022-03-15

Press Mentions

Addition of Icosapent Ethyl Cuts CV Risk in Patients with Prior PCIMarch 24th, 2022
Amarin’s Vascepa Shows Lower Risk of Fatal CV Events in REDUCE-IT Prior PCI Post Hoc SubanalysisMarch 10th, 2022
REDUCE-IT: Significant Reduction in Coronary Revascularizations with Icosapent EthylMay 15th, 2020